
Sign up to save your podcasts
Or
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
4.7
16041,604 ratings
Apple falls after CEO Tim Cook lowers revenue guidance for the 1st quarter. Bristol-Myers Squibb gives Celgene shareholders $74 billion reasons to smile. MFAM Funds portfolio manager Bill Barker analyzes the latest headlines and what it means for investors. Plus, we dip into the Fool Mailbag to discuss investing for your (adult) children. (Tangents include company rebranding fails, Harry Potter’s effect on today’s mega-merger, and why Bill hasn’t been in the studio in awhile.)
1,642 Listeners
4,080 Listeners
1,715 Listeners
496 Listeners
3,177 Listeners
826 Listeners
658 Listeners
3,364 Listeners
806 Listeners
938 Listeners
1,409 Listeners
1,022 Listeners
9,595 Listeners
880 Listeners
558 Listeners
545 Listeners
43 Listeners